Lat­est news on Covid vac­cine de­lay for kids; Door slammed shut for Chi­na-on­ly da­ta; Er­ic Lan­der is out; Look­ing back at the boom; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’ve been get­ting emails from read­ers ask­ing about one of our most pop­u­lar an­nu­al fea­tures — the End­points 20 un­der 40 — and when they can start nom­i­nat­ing peo­ple. Well, the an­swer is now. Tell us about the fresh-faced aca­d­e­mics or ex­ec­u­tives you be­lieve are be­hind the next big idea here. The dead­line is Feb­ru­ary 18.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER